BlackRock’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.5M Sell
1,007,143
-11,132
-1% -$352K ﹤0.01% 2687
2025
Q4
$22.2M Sell
1,018,275
-13,460
-1% -$280K ﹤0.01% 3039
2025
Q3
$22.2M Sell
1,031,735
-108,744
-10% -$2.44M ﹤0.01% 3039
2025
Q2
$29.3M Buy
1,140,479
+138,988
+14% +$4.07M ﹤0.01% 2803
2025
Q1
$36.7M Buy
1,001,491
+19,862
+2% +$683K ﹤0.01% 2552
2024
Q4
$30.1M Sell
981,629
-13,998
-1% -$465K ﹤0.01% 2787
2024
Q3
$37.5M Sell
995,627
-114,646
-10% -$4.42M ﹤0.01% 2659
2024
Q2
$44M Sell
1,110,273
-15,591
-1% -$505K ﹤0.01% 2492
2024
Q1
$37.8M Sell
1,125,864
-38,513
-3% -$1.29M ﹤0.01% 2614
2023
Q4
$38.8M Buy
1,164,377
+72,001
+7% +$2.32M ﹤0.01% 2638
2023
Q3
$34.3M Sell
1,092,376
-250,822
-19% -$7.89M ﹤0.01% 2627
2023
Q2
$42.6M Buy
1,343,198
+18,811
+1% +$608K ﹤0.01% 2584
2023
Q1
$43.8M Buy
1,324,387
+35,656
+3% +$1.17M ﹤0.01% 2538
2022
Q4
$41.5M Buy
1,288,731
+52,853
+4% +$1.8M ﹤0.01% 2597
2022
Q3
$44.1M Buy
1,235,878
+305,576
+33% +$12.7M ﹤0.01% 2535
2022
Q2
$38.2M Buy
930,302
+27,805
+3% +$1.35M ﹤0.01% 2671
2022
Q1
$52.3M Sell
902,497
-12,429
-1% -$680K ﹤0.01% 2561
2021
Q4
$53.8M Buy
914,926
+74,613
+9% +$4.53M ﹤0.01% 2615
2021
Q3
$51M Buy
840,313
+11,855
+1% +$695K ﹤0.01% 2651
2021
Q2
$49.7M Sell
828,458
-2,645
-0.3% -$133K ﹤0.01% 2709
2021
Q1
$39.2M Buy
831,103
+13,408
+2% +$552K ﹤0.01% 2785
2020
Q4
$30.7M Buy
817,695
+41,992
+5% +$1.38M ﹤0.01% 2776
2020
Q3
$25.4M Sell
775,703
-147,762
-16% -$6.26M ﹤0.01% 2728
2020
Q2
$41.9M Buy
923,465
+156,946
+20% +$8.02M ﹤0.01% 2366
2020
Q1
$35M Sell
766,519
-33,615
-4% -$1.52M ﹤0.01% 2285
2019
Q4
$34.6M Buy
800,134
+67,815
+9% +$2.76M ﹤0.01% 2578
2019
Q3
$26.5M Buy
732,319
+70,460
+11% +$2.97M ﹤0.01% 2656
2019
Q2
$31.1M Sell
661,859
-12,103
-2% -$512K ﹤0.01% 2590
2019
Q1
$23.7M Buy
673,962
+11,859
+2% +$466K ﹤0.01% 2661
2018
Q4
$24.8M Sell
662,103
-45,919
-6% -$1.79M ﹤0.01% 2602
2018
Q3
$24M Buy
708,022
+24,085
+4% +$705K ﹤0.01% 2767
2018
Q2
$17.1M Buy
683,937
+45,248
+7% +$1.26M ﹤0.01% 2952
2018
Q1
$19.1M Sell
638,689
-7,697
-1% -$258K ﹤0.01% 2804
2017
Q4
$20.7M Buy
646,386
+10,333
+2% +$333K ﹤0.01% 2766
2017
Q3
$19M Buy
636,053
+1,930
+0.3% +$52.8K ﹤0.01% 2839
2017
Q2
$14.8M Sell
634,123
-29,200
-4% -$679K ﹤0.01% 2954
2017
Q1
$14.5M Buy
663,323
+660,970
+28,091% +$14.9M ﹤0.01% 2937
2016
Q4
$53K Sell
2,353
-139
-6% -$3.35K ﹤0.01% 2901
2016
Q3
$57K Sell
2,492
-136
-5% -$3.04K ﹤0.01% 2899
2016
Q2
$57K Buy
2,628
+1,738
+195% +$54.7K ﹤0.01% 2869
2016
Q1
$31K Buy
890
+583
+190% +$15.4K ﹤0.01% 2613
2015
Q4
$8K Hold
307
﹤0.01% 2965
2015
Q3
$9K Hold
307
﹤0.01% 2758
2015
Q2
$13K Buy
+307
New +$14.5K ﹤0.01% 2617

Other funds holding ATEX

BlackRock's ATEX Position: Q1 2026 in Review

BlackRock reduced its Anterix (ATEX) stake by 1.1% in Q1 2026, selling an estimated $352K and leaving 1,007,143 shares worth $38.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2687.

BlackRock first reported a position in ATEX in Q2 2015 and has held it in 44 quarters since. The position peaked at $53.8M in Q4 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • BlackRock held 1,007,143 shares of Anterix worth $38.5M as of Q1 2026.
  • BlackRock sold 11,132 Anterix shares in Q1 2026, an estimated $352K.
  • Anterix made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2687 holding.
  • BlackRock first reported a position in Anterix in Q2 2015 and has held it in 44 quarters since.
  • BlackRock's Anterix position peaked at $53.8M in Q4 2021.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.